GeneDesign joins Ajinomoto Bio-pharma

Japan |  News | 0 Comment | 09 Apr, 2019

Ajinomoto Bio-Pharma, a leading provider of biopharmaceutical contract development and manufacturing services has a...Read more

Japan grants Sakigake designation to Eisai’s novel FGFR

Japan |  News | 0 Comment | 08 Apr, 2019

Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. The co...Read more

Clinigen K.K., GC Pharma sign pact to market Hunterase ICV

Japan |  News | 0 Comment | 05 Apr, 2019

Clinigen K.K. and GC Pharma have recently announced an exclusive licensing agreement in Japan to commercialize...Read more

Japan approves first drug for ADA deficiency

Japan |  News | 0 Comment | 04 Apr, 2019

Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, has announced that it has acqui...Read more

Takeda takes step towards EU Entyvio extension

Japan |  News | 0 Comment | 02 Apr, 2019

Takeda Pharmaceutical Company Limited announced that the European Medicines Agency (EMA) has accepted a Marketing Author...Read more

Chugai Pharma sells Ulcerlmin business to Fuji Chemical

Japan |  News | 0 Comment | 03 Apr, 2019

Chugai Pharmaceutical Co., Ltd., Tokyo and Fuji Chemical Industries Co., Ltd., Toyama announced that two companies ...Read more

Hitachi's Radiation Therapy Systems start operation in Nagamori Memorial Center

Japan |  News | 0 Comment | 02 Apr, 2019

Hitachi, Ltd. has announced that the radiation therapy started on April 1, 2019 at Nagamori Memorial Center of Innovativ...Read more

GHIT selects joint research project on dengue by Chugai, A*STAR

Japan |  News | 0 Comment | 02 Apr, 2019

Chugai Pharmaceutical Co., Ltd. has announced that a joint research project between Chugai and the Agency for Science, T...Read more

Takeda, StrideBio to advance novel gene therapies for neuro diseases

Japan |  News | 0 Comment | 01 Apr, 2019

StrideBio, Inc, a leading developer of novel adeno-associated viral (AAV) based gene therapies, recently announced the s...Read more

Daiichi Sankyo, AstraZeneca sign $6.9M deal for cancer drug

Japan |  News | 0 Comment | 29 Mar, 2019

Daiichi Sankyo Company, Limited has entered into a global development and commercialization agreement with AstraZeneca f...Read more

CPhI Japan sees Japanese R&D reinvigorated with international partnerships proliferating

Japan |  News | 1 Comment | 29 Mar, 2019

CPhI Japan closes as a new wave of innovation is rising across the country, driven by structural and regulatory changes....Read more

Japan approves Gilead’s Biktarvy to treat HIV-1 Infection

Japan |  News | 0 Comment | 28 Mar, 2019

Gilead Sciences, announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Bikta...Read more

GHIT Fund announces new investment worth 2.86B Yen

Japan |  News | 0 Comment | 28 Mar, 2019

The Global Health Innovative Technology (GHIT) Fund has announced a total of 2.86 billion yen to support 10 partnerships...Read more

Japan Health Ministry approves immunoglobulins to treat CIDP

Japan |  News | 0 Comment | 28 Mar, 2019

Global biotherapeutics leader CSL Behring recently announced that Japan's Ministry of Health, Labour and ...Read more

AbbVie gets the first global regulatory approval of SKYRIZI in Japan

Japan |  News | 0 Comment | 27 Mar, 2019

AbbVie, a research-based global biopharmaceutical company, has announced that the Japanese Ministry of Health, Labour an...Read more

Lupin, YL Biologics receive PMDA approval for Etanercept biosimilar in Japan

Japan |  News | 0 Comment | 26 Mar, 2019

Lupin has announced that YL Biologics Limited (YLB), a joint venture between Lupin’s subsidiary Lupin Atlantis Hol...Read more

Eisai starts Phase III clinical trial for Alzheimer's drug

Japan |  News | 0 Comment | 25 Mar, 2019

Eisai Co., Ltd. has announced that a global Phase III clinical study (Clarity AD/Study 301) of BAN2401, an anti-amyloid ...Read more

Eisai to present latest research on Alzheimer's Disease / Dementia Pipeline

Japan |  News | 0 Comment | 22 Mar, 2019

Eisai Co., Ltd. announced that a total of seven presentations highlighting the latest data on its Alzheimer's disease/de...Read more